跳至主要内容
临床试验/NCT00238576
NCT00238576已完成不适用

Lamotrigine in the Treatment of Bipolar Disorder in Women of Reproductive Age

Stanford University2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2008年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
2
主要终点
Changes in weight, glucose, lipid levels , insulin and testosterone concentrations over 6 months onmedication

研究概览

简要总结

This project will expand current knowledge of reproductive biology in women with bipolar disorder as well as assessing the impact of lamotrigine use for the treatment of bipolar disorder on reproductive function. Specifically, this study examines mood over the menstrual cycle and ovulation for three consecutive menstrual cycles in women treated for bipolar I, II, or NOS (not otherwise specified) with lamotrigine. In addition, testosterone and lipid concentrations will be measured before the participant starts receiving lamotrigine, as well as six months after receiving lamotrigine.

研究设计

研究类型
Observational
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Ages 18 through 45
  • Diagnosis of bipolar disorder (I, II, or NOS)
  • Willing to sign the Human Subject Protection Consent Form prior to enrollment into the study
  • Willing to use lamotrigine
  • Never used lamotrigine prior to study entry

排除标准

  • Unwilling or unable to comply with study requirements, e.g. complete forms, or attend scheduled evaluations
  • Significant alcohol and/or substance abuse or dependence within the prior 6 months
  • Used lamotrigine prior to study entry, or currently using lamotrigine at study entry

结局指标

主要结局

Changes in weight, glucose, lipid levels , insulin and testosterone concentrations over 6 months onmedication

时间窗: 6 months

This is a research study to determine how effective lamotrigine is in the treatment of bipolar disorder in women of reproductive age. Participants are between the ages of 18 and 45, have been diagnosed with bipolar disorder, and have indicated that they are about to begin or are considering treatment with lamotrigine. The purposes of this study are to explore the safety of lamotrigine in treating bipolar I disorder, bipolar II disorder, and rapid cycling bipolar disorder in women compared to other mood stabilizers and anti-depressants. In addition, this study aims to explore lamotrigine's effects on the association between the mood and the menstrual cycle and to compare the effects of various medications that participants receive for treatment of their illness in regards to reproductive hormone levels.

次要结局

  • Menstrual cycle length and presence or absence of ovulation(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Natalie Rasgon

Principal Investigator

Stanford University

研究点 (2)

Loading locations...

相似试验